Ramsay Health Care Ltd (ASX: RHC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Ramsay Health Care Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Ramsay Health Care Ltd (ASX: RHC)
Latest News
Share Market News
Top broker says Ramsay Health Care Limited (ASX:RHC) shares are a sell
Defensive Shares
3 high quality blue chips I want to buy
Share Market News
Why another top broker just upgraded Primary Health Care Limited (ASX:PRY) to "buy"
Share Market News
The private hospital sector is under pressure
Growth Shares
2 companies cashing in on the ageing population
Share Market News
Top broker says sell Ramsay Health Care Limited (ASX:RHC) and buy ResMed Inc (ASX:RMD) shares
Share Market News
5 things to watch on the ASX on Tuesday
Share Market News
Another common stock market mistake to avoid: "The market's crashing – I've gotta get out!"
Growth Shares
A quick check-up on these 3 S&P/ASX 200 healthcare stocks
Share Market News
Is the Ramsay Health Care Limited (ASX:RHC) share price a buy?
Share Market News
The 3 biggest disappointments during earnings season
⏸️ ASX Shares
Should you buy Ramsay Health Care Limited (ASX:RHC) shares?
Frequently Asked Questions
-
Yes, Ramsay Health Care has historically paid two fully franked dividends a year.
-
Ramsay Health Care generally pays its shareholder dividends in March and September.
-
Ramsay Health Care Ltd listed on the ASX on 24 September 1997.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 03 Sep 2025 | $0.4000 | 100.00% | Final | 25 Sep 2025 |
| 06 Mar 2025 | $0.4000 | 100.00% | Interim | 27 Mar 2025 |
| 04 Sep 2024 | $0.4000 | 100.00% | Final | 26 Sep 2024 |
| 11 Mar 2024 | $0.4000 | 100.00% | Interim | 05 Apr 2024 |
| 06 Sep 2023 | $0.2500 | 100.00% | Final | 29 Sep 2023 |
| 06 Mar 2023 | $0.5000 | 100.00% | Interim | 30 Mar 2023 |
| 05 Sep 2022 | $0.4850 | 100.00% | Final | 29 Sep 2022 |
| 07 Mar 2022 | $0.4850 | 100.00% | Interim | 31 Mar 2022 |
| 06 Sep 2021 | $1.0300 | 100.00% | Final | 30 Sep 2021 |
| 08 Mar 2021 | $0.4850 | 100.00% | Interim | 31 Mar 2021 |
| 05 Mar 2020 | $0.6250 | 100.00% | Interim | 27 Mar 2020 |
| 05 Sep 2019 | $0.9150 | 100.00% | Final | 30 Sep 2019 |
| 06 Mar 2019 | $0.6000 | 100.00% | Interim | 29 Mar 2019 |
| 05 Sep 2018 | $0.8650 | 100.00% | Final | 28 Sep 2018 |
| 06 Mar 2018 | $0.5750 | 100.00% | Interim | 29 Mar 2018 |
| 05 Sep 2017 | $0.0000 | 100.00% | Final | 28 Sep 2017 |
| 07 Mar 2017 | $0.5300 | 100.00% | Interim | 29 Mar 2017 |
| 06 Sep 2016 | $0.7200 | 100.00% | Final | 29 Sep 2016 |
| 08 Mar 2016 | $0.4700 | 100.00% | Interim | 30 Mar 2016 |
| 08 Sep 2014 | $0.5100 | 100.00% | Final | 24 Sep 2014 |
| 04 Mar 2014 | $0.3400 | 100.00% | Interim | 26 Mar 2014 |
| 03 Sep 2013 | $0.4150 | 100.00% | Final | 25 Sep 2013 |
| 04 Mar 2013 | $0.2900 | 100.00% | Interim | 27 Mar 2013 |
| 05 Mar 2012 | $0.2550 | 100.00% | Interim | 28 Mar 2012 |
| 02 Sep 2011 | $0.2950 | 100.00% | Final | 26 Sep 2011 |
| 08 Mar 2011 | $0.2250 | 100.00% | Interim | 28 Mar 2011 |
| 31 Aug 2010 | $0.2500 | 100.00% | Final | 27 Sep 2010 |
| 16 Mar 2010 | $0.1850 | 100.00% | Interim | 09 Apr 2010 |
| 21 Sep 2009 | $0.2150 | 100.00% | Final | 09 Oct 2009 |
| 20 Mar 2009 | $0.1650 | 100.00% | Interim | 08 Apr 2009 |
| 25 Sep 2008 | $0.1750 | 100.00% | Final | 15 Oct 2008 |
| 26 Sep 2007 | $0.1600 | 100.00% | Final | 12 Oct 2007 |
| 27 Mar 2006 | $0.1050 | 100.00% | Interim | 12 Apr 2006 |
| 26 Sep 2005 | $0.1150 | 100.00% | Final | 14 Oct 2005 |
| 16 Apr 2004 | $0.0750 | 100.00% | Interim | 30 Apr 2004 |
RHC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Ramsay Health Care Ltd
Ramsay Health Care Ltd (ASX: RHC) is one of the largest private healthcare providers in the world, with around 500 facilities across 11 countries. Its operations cover Australia, Europe, the UK, and Asia.
As well as private hospitals, Ramsay operates day surgeries, primary care clinics, diagnostic and imaging centres, mental health facilities, pharmacies, and an expanding range of in-home and community care services.
It is the largest private hospital group in Australia, France, and the Scandanavian countries. Its 52.5%-owned subsidiary Ramsay Sante oversees its European operations. Its UK business includes mental health facilities and a range of clinical specialties.
The vast majority of the company's revenue is generated from its Australian and European operations.
RHC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 13 Jan 2026 | $35.88 | $-0.07 | -0.19% | 396,960 | $36.19 | $36.62 | $35.88 |
| 12 Jan 2026 | $35.95 | $0.60 | 1.70% | 280,470 | $35.40 | $36.01 | $35.39 |
| 09 Jan 2026 | $35.35 | $-0.33 | -0.92% | 385,048 | $35.68 | $35.99 | $35.26 |
| 08 Jan 2026 | $35.68 | $0.75 | 2.15% | 392,670 | $34.75 | $35.81 | $34.75 |
| 07 Jan 2026 | $34.93 | $-0.02 | -0.06% | 441,525 | $34.95 | $35.17 | $34.74 |
| 06 Jan 2026 | $34.95 | $0.04 | 0.11% | 412,448 | $34.83 | $35.07 | $34.53 |
| 05 Jan 2026 | $34.91 | $0.32 | 0.93% | 246,148 | $34.50 | $34.93 | $34.50 |
| 02 Jan 2026 | $34.59 | $0.23 | 0.67% | 151,659 | $34.43 | $34.79 | $34.38 |
| 31 Dec 2025 | $34.36 | $-0.08 | -0.23% | 238,767 | $34.69 | $34.69 | $34.27 |
| 30 Dec 2025 | $34.44 | $-0.12 | -0.35% | 305,939 | $34.75 | $34.85 | $34.39 |
| 29 Dec 2025 | $34.56 | $-0.63 | -1.79% | 293,985 | $35.47 | $35.47 | $34.43 |
| 24 Dec 2025 | $35.19 | $-0.32 | -0.90% | 142,822 | $35.17 | $35.41 | $35.11 |
| 23 Dec 2025 | $35.51 | $1.00 | 2.90% | 437,212 | $34.77 | $35.72 | $34.71 |
| 22 Dec 2025 | $34.51 | $-0.09 | -0.26% | 266,143 | $34.50 | $34.97 | $34.38 |
| 19 Dec 2025 | $34.60 | $0.50 | 1.47% | 1,859,246 | $34.03 | $34.60 | $33.90 |
| 18 Dec 2025 | $34.10 | $-0.14 | -0.41% | 511,488 | $34.15 | $34.21 | $33.78 |
| 17 Dec 2025 | $34.24 | $-0.66 | -1.89% | 401,668 | $34.92 | $34.92 | $34.17 |
| 16 Dec 2025 | $34.90 | $-0.45 | -1.27% | 747,574 | $35.05 | $35.48 | $34.69 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 15 Dec 2025 | Natalie Davis | Issued | 74,075 | $2,618,551 |
Issue of securities. 131,547 Performance Rights
|
| 26 Nov 2025 | Natalie Davis | Issued | 21,071 | $675,011 |
Director remuneration. VWAP
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr David Ingle Thodey | Non-Executive DirectorNon-Executive Chairman | Nov 2017 |
Mr Thodey is a business leader focused on innovation, technology, digital transformation, and corporate governance, with more than 40 years of experience. In addition to being Chair he is currently Chair of Xero Limited, Chancellor the University of Sydney, and co-Chair of the Great Barrier Reef Foundation. He is also a non-executive member of the Reserve Bank of Australia Governance Board. He is Chair of Governance Committee.
|
| Ms Catriona Alison Deans | Non-Executive Director | Nov 2018 |
Ms Deans has 25 years of experience building technology-enabled businesses involved in media, ecommerce, financial services, and health, and across leadership roles as an executive, a director and in venture capital. She is also Chair of Cochlear Limited, Chair of Calix Limited and a Non-Executive Director of Fitness Passport, The Observership Program and Deputy Pty Ltd. She is also a Venture Partner of Main Sequence Ventures. In her executive career, she was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas and most recently CEO of Netus Pty Ltd (a technology investment company acquired by Fairfax). She also spent seven years as a consultant with McKinsey and Company. She is also a member of Governance Committee.
|
| Mr Michael Stanley Siddle | Non-Executive Director | May 1975 |
Mr Siddle has experience in the management of private hospitals and has been involved in expansion through developments, mergers and acquisitions. He is also member of Governance Committee.
|
| Mr Craig Milton Drummond | Non-Executive Director | Jul 2025 |
Mr Drummond brings executive and board-level experience across healthcare, financial services, and other regulated industries. He is also Chair of Transurban Group, Chair of the Australian Foundation Investment Company Limited, and Chair of The Ian Potter Foundation. He has previously served as President and Director of the Geelong Football Club Ltd, a Director of the Florey Institute of Neuroscience and Mental Health, and a Member of the Federal Government's Financial Regulator Assessment Authority. His executive career includes five years as Chief Executive Officer of Medibank Private Ltd (2016-2021). He was formerly Group Executive Finance and Strategy at National Australia Bank, and Chief Executive Officer and Country Head at Bank of America Merrill Lynch (Australia).
|
| Ms Helen Kurincic | Non-Executive Director | Mar 2024 |
Ms Kurincic is member of Risk Management Committee. She brings operational, executive and board-level experience in a range of Australian based healthcare organisations. In addition to serving on the Ramsay Board, she is currently Chair of McMillan Shakespeare and a director of Carlton Football Club. Her previous health sector roles include Non-Executive Director of private health insurer HBF Health, Estia Health, Integral Diagnostics (Chair), Sirtex Medical, Domain Principal Group, public hospital service provider Melbourne Health, Orygen Youth Mental Health Research Centre and DCA Group.
|
| Ms Karen Lee Collett Penrose | Non-Executive Director | Mar 2020 |
Ms Penrose is member of Risk Management Committee. She has had an executive career in leadership and CFO roles, in financial services. She has experience in financial management, customer outcomes and operating in a rapidly changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed-company CFO. She has been a full-time director since 2014 and is a committee chair of audit and risk.
|
| Mr Steven Andrew Sargent | Non-Executive Director | Nov 2021 |
Mr Sargent is Chair of Risk Management Committee. His executive career included 22 years at General Electric, where he gained multi-industry, international experience leading businesses in industries including healthcare, energy and financial services across the USA, Europe, and Asia Pacific. In addition to being a Non-Executive Director of Ramsay, he also serves as a Director of Ramsay Generale de Sante and is the Chair of infection prevention company Nanosonics Limited. His unlisted board activities include Chairman of The Origin Foundation Limited, Origin's philanthropic arm, and Non-Executive Director of The Great Barrier Reef Foundation.
|
| Ms Claudia Ricarda Rita Sussmuth Dyckerhoff | Non-Executive Director | Oct 2018 |
Ms Dyckerhoff brings expertise in market growth strategies, business development and operational performance improvement in hospitals. She has global experience in hospitals and health care across Europe, Asia, and the USA. She joined McKinsey & Company in Switzerland in 1995 and transferred to the USA focusing on supporting health care companies, including pharmaceutical/medical device companies, payor, provider and health systems in Europe and the USA. In 2006, she transferred to China, was elected Senior Partner in 2010 and supported health care companies as well as governments across Asia. She is member of Risk Management Committee.
|
| Mr Natalie Davis | Chief Executive OfficerManaging Director | Dec 2024 |
Ms Davis has experience driving strategic transformation, customer focus and growth. She joined Ramsay after a decade with the Woolworths Group, where she held several roles including as Managing Director of Woolworths Supermarkets, Chief Customer Transformation Officer and Managing Director Woolworths NZ.
|
| Ms Henrietta Rowe | Company SecretaryGroup General Counsel | Jun 2019 |
-
|
| Michael Hirner | Acting Group Executive Finance |
-
|
|
| Henrietta Rowe | Company SecretaryGroup General Counsel |
-
|
|
| Brindan Suresh | Group Executive Health and Strategy |
-
|
|
| Colleen Harris | Group Executive People and Sustainability |
-
|
|
| Pascal Roche | Managing Director Ramsay Sante |
-
|
|
| Nick Costa | Managing Director UK Hospitals Acting Managing Director Elysium |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 48,815,874 | 21.15% |
| J P Morgan Nominees Australia Pty Limited | 36,515,720 | 15.82% |
| Netwealth Investments Limited <Wrap Services A/C> | 33,792,188 | 14.64% |
| Paul Ramsay Holdings Pty Limited | 22,346,876 | 9.68% |
| Citicorp Nominees Pty Limited | 8,187,680 | 3.55% |
| National Nominees Limited | 7,230,630 | 3.13% |
| Woolwich Investments Pty Ltd <The Siddle Family Trust> | 3,238,259 | 1.40% |
| BNP Paribas Noms Pty Ltd | 3,147,220 | 1.36% |
| Washington H Soul Pattinson And Company Limited | 2,758,806 | 1.20% |
| BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 2,750,000 | 1.19% |
| Argo Investments Limited | 2,747,673 | 1.19% |
| BNP Paribas Nominees Pty Ltd <Agency Lending Collateral > | 2,721,314 | 1.18% |
| Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> | 2,057,299 | 0.89% |
| Custodial Services Limited <Beneficiaries Holding A/C> | 1,028,000 | 0.45% |
| HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> | 780,296 | 0.34% |
| BNP Paribas Nominees Pty Ltd <Agency Lending A/C> | 721,395 | 0.31% |
| HSBC Custody Nominees (Australia) Limited Gsi Eda | 710,830 | 0.31% |
| Australian Foundation Investment Company Limited | 625,740 | 0.27% |
| UBS Nominees Pty Ltd | 575,000 | 0.25% |
| Certane Ct Pty Ltd <Ramsay Unallocated Ac> | 574,899 | 0.25% |